Antihypertensive therapy and atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Metabolic Disorders

Background:

• Hypertension and atherosclerosis are key contributors to cardiovascular disease pathogenesis.
• Some antihypertensive drugs, like diuretics and beta adrenergic blockers, can negatively affect lipid metabolism.
• Other antihypertensive classes generally do not exhibit adverse lipid effects.

Purpose of the Study:

• To recommend a vascular biological approach for managing patients with both hypertension and atherosclerosis.
• To highlight the importance of selecting antihypertensive agents that do not adversely affect lipid metabolism.
• To emphasize the dual treatment strategy for blood pressure and lipid disorders.

Main Methods:

• Review of existing literature on antihypertensive medications and their effects on lipid metabolism.
• Analysis of animal model studies investigating the anti-atherogenic effects of various drug classes.
• Synthesis of findings to propose a therapeutic strategy.

Main Results:

• Diuretics and beta adrenergic blockers can have adverse effects on lipid profiles.
• Beta adrenergic blockers, angiotensin converting enzyme (ACE) inhibitors, and calcium antagonists demonstrated anti-atherogenic effects in animal models.
• A combined approach targeting both blood pressure and lipid disorders is beneficial.

Conclusions:

• A vascular biological approach is recommended for patients with comorbid hypertension and atherosclerosis.
• Prioritize blood pressure reduction using agents with neutral or beneficial effects on lipid metabolism.
• Simultaneous treatment of lipid metabolism disorders is crucial for comprehensive cardiovascular care.